Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

AstraZeneca

AstraZeneca Q3 profit rises, reconfirms full-year guidance

AstraZeneca reported third-quarter profit of $3.12 billion, up from $2.53 billion a year earlier. The company reiterated its full-year 2026 revenue and core EPS targets.

AZN+2.9%

Illustration for the Business desk

The stocks in this story

  1. AZN+2.9%AstraZeneca$174.40

Prices from Before the open · based on Thu close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.